Bluelinea Société Anonyme (EPA:ALBLU)
France · Delayed Price · Currency is EUR 0.2200
0.00 (0.00%)
Jul 31, 2026, 10:05 AM CET
Bluelinea Société Anonyme Revenue
In the year 2025, Bluelinea Société Anonyme had annual revenue of 10.73M EUR with 9.37% growth. Bluelinea Société Anonyme had revenue of 5.20M in the half year ending December 31, 2025, with 3.74% growth.
Revenue
10.73M
Revenue Growth
+9.37%
P/S Ratio
0.36
Revenue / Employee
124.96K
Employees
89
Market Cap
4.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.73M | 919.44K | 9.37% |
| Dec 31, 2024 | 9.81M | -83.74K | -0.85% |
| Dec 31, 2023 | 9.89M | -569.64K | -5.45% |
| Dec 31, 2022 | 10.46M | 2.92M | 38.64% |
| Dec 31, 2021 | 7.55M | 613.84K | 8.86% |
| Dec 31, 2020 | 6.93M | -912.64K | -11.63% |
| Dec 31, 2019 | 7.84M | 1.68M | 27.30% |
| Dec 31, 2018 | 6.16M | 260.00K | 4.41% |
| Dec 31, 2017 | 5.90M | 178.00K | 3.11% |
| Dec 31, 2016 | 5.72M | 460.96K | 8.76% |
| Dec 31, 2015 | 5.26M | 3.36M | 176.48% |
| Dec 31, 2014 | 1.90M | 798.64K | 72.28% |
| Dec 31, 2013 | 1.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Eurobio Scientific Société anonyme | 168.60M |
| Biosynex | 95.19M |
| Diagnostic Medical Systems | 52.86M |
| Median Technologies | 23.47M |
| Novacyt | 22.96M |
| Implanet | 12.47M |
| Mauna Kea Technologies | 8.91M |